1-(4-((4-([1,2,4]Triazolo[1,5-a]pyrid-7-yloxy)-3-methylphenyl)amino)quinazolin-6-yl)-3-(1-hydroxy-2-methylpropan-2-yl)thiourea

The structure integrates multiple privileged scaffolds—quinazoline, triazolopyridine, and thiourea—often seen in targeted small-molecule drug discovery, especially kinase- and enzyme-focused programs. 1-(4-((4-([1,2,4]Triazolo[1,5-a]pyrid-7-yloxy)-3-methylphenyl)amino)quinazolin-6-yl)-3-(1-hydroxy-2-methylpropan-2-yl)thiourea is a highly complex, heterocycle-rich compound used as a late-stage pharmaceutical intermediate or medicinal chemistry lead.